Navigation Links
Sabre 180, 110V, 60Hz

ProductsSabre 180, 110V, 60Hz
Company CONMED Corporation
Item Sabre 180, 110V, 60Hz
Features ARM Contact Quality (sensitive pad monitoring system)
Description Sabre 180 is a powerful niche generator.
Info CONMED Corporation
Customer Service: (315) 797-8375
Web site: http://www.conmed.com/

Related medicine products :

1. Sabre 2400
2. Sabre 180
3. Sabre 2400, 110V, 60Hz
4. Sabre 2400, 100V, 50Hz/60Hz
5. Sabre 2400, 220V, 50Hz
6. Sabre 2400, 240V, 50Hz
7. Sabre 180, 230V, 50Hz
8. Sabre 180, 100V, 50Hz/60Hz
9. Sabre 2400 Electrosurgery Generator, 110V, 60Hz
10. Sabre 2400 Electrosurgery Generator, 100V, 50Hz/60Hz
11. Sabre 2400 Electrosurgery Generator, 220V, 50Hz
TAG: Sabre
Breaking Medicine Technology:Cambridge Scientists Archive 500,000th Crystal Structure 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Covance Inc Invites You to Join the Webcast of Its Second Quarter 2009 Financial Results Conference Call 50805 1Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease 4686 1Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease 4686 2Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease 4686 3Living Medical Textbook 28TM 29 from Projects In Knowledge 28R 29 50802 1Living Medical Textbook 28TM 29 from Projects In Knowledge 28R 29 50802 2Living Medical Textbook 28TM 29 from Projects In Knowledge 28R 29 50802 3